Learn how labman is advancing biologics manufacturing through AI-powered bioreactor technology, driving innovation in drug development.
Yokogawa defines autonomous control AI as AI that deduces the optimum method for control independently, and has a high level ...
Outcome of Regenerative Medicine Advanced Therapy (RMAT) meeting provides the potential for an accelerated regulatory pathway to approval of ...
The Global AI on EDGE Semiconductor Market was valued at USD 3246 Million in the year 2024 and is projected to reach a revised size of USD 9342 Million by 2031, growing at a CAGR of 16.5% during the ...
Yeşim Group received the Innovation award in the 2025 Just Style Excellence Awards for its integration of automated, ...
The computing world is on the cusp of a transformation. Rather than simply getting a little faster each year, desktop PCs are approaching a leap in capability t ...
A timely book that highlights operational details and the thought process behind conducting an integrated joint operation in response to the attack on tourists in Pahalgam in April 2025 ...
9hon MSNOpinion
Why data sovereignty is essential to help businesses prepare for impending AI regulation
Establishing true data sovereignty is the most effective way to tackle these risks. It ensures that sensitive data is not ...
Cutting-edge soil analysis techniques from LECO are revolutionizing carbon and nitrogen measurement, crucial for sustainable ...
As part of this transformation, JCI Mining successfully completed the integration of Sage X3 with its Asset Management and ...
Industrial performance aligns with broader NYSE Composite activity. The company’s technological integration drives continued operational growth. Celestica Inc. (NYSE:CLS) operates as a global provider ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results